Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: December 2, 2021

DrugPatentWatch Database Preview

Patent: 7,947,272

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 7,947,272
Title:Compositions and methods of tolerizing a primate to an antigen
Abstract: Inducing tolerance in a primate by use of a compound, or a combination of at least two compounds, that has certain characteristics when tested in vitro. The compound, alone or in combination, is preferably TRX1 antibody and the compound or combination is preferably used in accordance with a specified dosing regimen.
Inventor(s): Frewin; Mark (Oxford, GB), Waldmann; Herman (Oxford, GB), Gorman; Scott (Whitney, GB), Hale; Geoff (Marston, GB), Rao; Patricia (Acton, MA), Kornaga; Tadeusz (Cambridge, MA), Ringler; Douglas (Boston, MA), Cobbold; Stephen (Witney, GB), Winsor-Hines; Dawn (Framingham, MA)
Assignee: Tolerx, Inc. (Cambridge, MA) Isis Innovation, Ltd. (Oxford, GB) Cambridge University Technical Services, Ltd. (Cambridge, GB)
Application Number:11/486,293
Patent Claims:see list of patent claims

Details for Patent 7,947,272

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Genentech, Inc. RITUXAN rituximab Injection 103705 1997-11-26 ⤷  Free Forever Trial 2021-06-14
Idec Pharmaceuticals Corp. RITUXAN rituximab Injection 103737 2002-02-19 ⤷  Free Forever Trial 2021-06-14
Genentech, Inc. RITUXAN HYCELA rituximab and hyaluronidase human Injection 761064 2017-06-22 ⤷  Free Forever Trial 2021-06-14
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.